PAPER De Beaumont L, Tremblay S, Henry LC, Poirier J, Lassonde M, Théoret H
SEARCH RESULTS
331254 RESULTS
PAPER Lungu G, Stoica G, Ambrus A
MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model.
Neurosci Lett. 2013 Oct 11;553:153-8. PubMed: 23973300PAPER Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F
Glutathione peroxidase activity is neuroprotective in models of Huntington's disease.
Nat Genet. 2013 Oct;45(10):1249-54. PubMed: 23974869PAPER Grossman M, Mickanin J, Onishi K, Hughes E, D'Esposito M, Ding XS, Alavi A, Reivich M
Progressive Nonfluent Aphasia: Language, Cognitive, and PET Measures Contrasted with Probable Alzheimer's Disease.
J Cogn Neurosci. 1996 Spring;8(2):135-54. PubMed: 23971420PAPER Brady CB, Trevor KT, Stein TD, Deykin EY, Perkins SD, Averill JG, Guilderson L, McKee AC, Renner SW, Kowall NW
The Department of Veterans Affairs Biorepository Brain Bank: A national resource for amyotrophic lateral sclerosis research.
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):591-7. PubMed: 23971854PAPER Morimoto BH, Fox AW, Stewart AJ, Gold M
Davunetide: A review of safety and efficacy data with a focus on neurodegenerative diseases.
Expert Rev Clin Pharmacol. 2013 Sep;6(5):483-502. PubMed: 23971871PAPER McGlynn SM, Kaszniak AW
When metacognition fails: impaired awareness of deficit in Alzheimer's disease.
J Cogn Neurosci. 1991 Spring;3(2):183-7. PubMed: 23972092PAPER Bayles KA, Tomoeda CK, Kaszniak AW, Trosset MW
Alzheimer's disease effects on semantic memory: loss of structure or impaired processing?
J Cogn Neurosci. 1991 Spring;3(2):166-82. PubMed: 23972091PAPER Chan AS, Butters N, Paulsen JS, Salmon DP, Swenson MR, Maloney LT
An assessment of the semantic network in patients with Alzheimer's disease.
J Cogn Neurosci. 1993 Spring;5(2):254-61. PubMed: 23972157PAPER Lu DF, Hart LK, Lutgendorf SK, Oh H, Schilling M
Slowing progression of early stages of AD with alternative therapies: A feasibility study.
Geriatr Nurs. 2013 Aug 22; PubMed: 23972540PAPER Orta-Salazar E, Feria-Velasco A, Medina-Aguirre GI, Díaz-Cintra S
Morphological analysis of the hippocampal region associated with an innate behaviour task in the transgenic mouse model (3xTg-AD) for Alzheimer disease.
Neurologia. 2013 Oct;28(8):497-502. PubMed: 23972735PAPER McClean PL, Hölscher C
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
Neuropharmacology. 2013 Aug 21; PubMed: 23973293PAPER Mota SI, Ferreira IL, Rego AC
Dysfunctional synapse in Alzheimer's disease- A focus on NMDA receptors.
Neuropharmacology. 2014 Jan;76 Pt A:16-26. PubMed: 23973316PAPER Kuang X, Chen YS, Wang LF, Li YJ, Liu K, Zhang MX, Li LJ, Chen C, He Q, Wang Y, Du JR
Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
Neurobiol Aging. 2014 Jan;35(1):169-78. PubMed: 23973442PAPER Kim SJ, Ahn JW, Kim H, Ha HJ, Lee SW, Kim HK, Lee S, Hong HS, Kim YH, Choi CY
Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
Biochem Biophys Res Commun. 2013 Sep 20;439(2):252-7. PubMed: 23973487Current Filters
No filters selected